Ambalal Sarabhai Enterprises Limited Share Price & Company Info
- Market cap
- ₹268 Cras reported by NSE
- 52-week high
- ₹49.9810-AUG-2026
- 52-week low
- ₹30.1523-JUL-2026
- Face value
- ₹10.00
- Shares issued
- 7,66,33,296
- Volume
- 61,046₹0.24 Cr traded
- Price band
- 5%₹33.79 – ₹37.33 on 2026-10-28
- Annual volatility
- 63.43%NSE, from daily returns
- Series
- BEtrade-for-trade
- BSE group
- Tscrip code 500009
- ISIN
- INE432A01017
- Listed on NSE
- 20-Apr-2026
About Ambalal Sarabhai Enterprises Limited
Ambalal Sarabhai Enterprises Limited is listed on the National Stock Exchange of India under the symbol AMBALALSA in the BE series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 20-Apr-2026. Each share has a face value of ₹10.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹38.62, up 1.02% on the day. NSE puts the company's market capitalisation at about ₹268 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹30.15 and ₹49.98, so the last price is 28.1% above the low and 22.7% below the high.
BE is a trade-for-trade series: every buy must be taken as delivery and every sell must be delivered, so intraday trading is not allowed. Exchanges move stocks here for surveillance reasons, often because of unusual price or volume behaviour.
NSE currently lists a regulatory note for this stock: ESM-1 | Less than 100 unique PAN traded in prev. 30 days, NSE's Enhanced Surveillance Measure for micro and small companies; at stage I every trade is settled by delivery (trade-for-trade) and a 100% margin applies. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.
NSE puts the stock's annualised volatility at 63.43%. That is very high: moves of several percent in a single day are routine.
Because the share trades below ₹50, it also appears in our list of penny stocks under ₹50, which explains the extra risks that come with low-priced shares.
Ambalal Sarabhai Enterprises Limited share price performance
Over the past year the Ambalal Sarabhai Enterprises Limited share price has gained 0.00%, against a fall of 12.39% for the NIFTY 50, so it has outperformed that index by 12.39 percentage points.
Across the 4 periods in the table, the stock beat the NIFTY 50 in 3. Past returns describe what happened; they do not predict what comes next.
| Period | AMBALALSA | NIFTY 50 |
|---|---|---|
| 1 month | -14.09% | -1.69% |
| 3 months | +11.74% | -5.19% |
| 6 months | +0.14% | -5.57% |
| 1 year | 0.00% | -12.39% |
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Ambalal Sarabhai Enterprises Limited.
Where to find Ambalal Sarabhai Enterprises Limited's financials
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “AMBALALSA” to download Ambalal Sarabhai Enterprises Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “AMBALALSA” for quarterly results, board meetings and other company filings.
- BSE quote page (500009)BSE price, filings, results and shareholding for the same company.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Pharmaceuticals stocks on MCX Trends
- Syncom Formulations (India) Limited (SYNCOMF · ₹21.19)
- Anlon Healthcare Limited (AHCL · ₹25.77)
- Sigachi Industries Limited (SIGACHI · ₹28.16)
- Vineet Laboratories Limited (VINEETLAB · ₹37.52)
- Medico Remedies Limited (MEDICO · ₹18.31)
- Nectar Lifesciences Limited (NECLIFE · ₹10.31)
- Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM · ₹30.67)
- Mangalam Drugs And Organics Limited (MANGALAM · ₹28.60)
Frequently asked questions
What is the Ambalal Sarabhai Enterprises Limited share price?
Ambalal Sarabhai Enterprises Limited (NSE: AMBALALSA) closed at ₹38.62 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does Ambalal Sarabhai Enterprises Limited belong to?
NSE classifies Ambalal Sarabhai Enterprises Limited under Pharmaceuticals, in the Healthcare sector.
What is the 52-week high and low of AMBALALSA?
The 52-week high is ₹49.98 (10-AUG-2026) and the 52-week low is ₹30.15 (23-JUL-2026), according to NSE.
Is Ambalal Sarabhai Enterprises Limited a penny stock?
At ₹38.62 the share trades below ₹50, so it appears on our list of penny stocks under ₹50. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
Where can I find Ambalal Sarabhai Enterprises Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for AMBALALSA) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.